Marshall Wace North America’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $84.5M | Buy |
204,845
+24,726
| +14% | +$10.2M | 0.36% | 55 |
|
|
2021
Q2 | $66.6M | Sell |
180,119
-13,470
| -7% | -$4.98M | 0.28% | 73 |
|
|
2021
Q1 | $56.1M | Buy |
+193,589
| New | +$56.1M | 0.23% | 98 |
|
|
2020
Q3 | – | Sell |
-14,903
| Closed | -$2.6M | – | 1252 |
|
|
2020
Q2 | $2.6M | Buy |
+14,903
| New | +$2.6M | 0.02% | 513 |
|
|
2019
Q4 | – | Sell |
-27,777
| Closed | -$3.68M | – | 1331 |
|
|
2019
Q3 | $3.68M | Buy |
+27,777
| New | +$3.68M | 0.02% | 423 |
|
|
2019
Q2 | – | Sell |
-508
| Closed | -$74K | – | 1233 |
|
|
2019
Q1 | $74K | Sell |
508
-1,022
| -67% | -$149K | ﹤0.01% | 1174 |
|
|
2018
Q4 | $173K | Buy |
+1,530
| New | +$173K | ﹤0.01% | 981 |
|
|
2018
Q3 | – | Sell |
-57,307
| Closed | -$6.43M | – | 992 |
|
|
2018
Q2 | $6.43M | Buy |
+57,307
| New | +$6.43M | 0.04% | 452 |
|
|
2017
Q4 | – | Sell |
-58,103
| Closed | -$6.28M | – | 1403 |
|
|
2017
Q3 | $6.28M | Sell |
58,103
-50,672
| -47% | -$5.47M | 0.04% | 482 |
|
|
2017
Q2 | $11M | Sell |
108,775
-328,504
| -75% | -$33.2M | 0.08% | 298 |
|
|
2017
Q1 | $39.4M | Buy |
+437,279
| New | +$39.4M | 0.31% | 90 |
|